Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Spoladore

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Heart (British Cardiac Society)|August 2, 2013
Coronary microvascular dysfunction in primary cardiomyopathiesR Spoladore, A Fisicaro, A Faccini, et al.
Expert Opinion on Pharmacotherapy|January 3, 2020
Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathyR Spoladore, G Fragasso, L Pannone, et al.
International Journal of Cardiology|May 16, 2012
Myocardial infarction in the youngR D'Amato, R Spoladore, A Esposito, et al.
Minerva Cardioangiologica|October 13, 2010
NYHA Class II subgrouping: correlation with left ventricular dysfunction questionnaire (LVD-36) and ejection fractionR Spoladore, G Fragasso, C Montanaro, et al.
Expert Opinion on Pharmacotherapy|October 12, 2020
Advances in pharmacotherapy for cardiac amyloidosisR Spoladore, G Falasconi, M Marcatti, et al.
International Journal of Cardiology|January 10, 2026
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access programG Bonacchi, A Del Franco, P G Agostoni, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Heart (British Cardiac Society)|August 2, 2013
Coronary microvascular dysfunction in primary cardiomyopathiesR Spoladore, A Fisicaro, A Faccini, et al.
Expert Opinion on Pharmacotherapy|January 3, 2020
Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathyR Spoladore, G Fragasso, L Pannone, et al.
International Journal of Cardiology|May 16, 2012
Myocardial infarction in the youngR D'Amato, R Spoladore, A Esposito, et al.
Minerva Cardioangiologica|October 13, 2010
NYHA Class II subgrouping: correlation with left ventricular dysfunction questionnaire (LVD-36) and ejection fractionR Spoladore, G Fragasso, C Montanaro, et al.
Expert Opinion on Pharmacotherapy|October 12, 2020
Advances in pharmacotherapy for cardiac amyloidosisR Spoladore, G Falasconi, M Marcatti, et al.
International Journal of Cardiology|January 10, 2026
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access programG Bonacchi, A Del Franco, P G Agostoni, et al.
Pageof 1